| Mar 5, 2026 | Cognito Therapeutics | $105.0M Series C | IAG Capital Partners, Gerald Chan, Starbloom Capital | Apollo Health Ventures, Benvolio Group, New Vintage |
| Feb 5, 2026 | Angitia Biopharmaceuticals | $130.0M Series D | Frazier Life Sciences, Venrock | 3H Health Investment, Ascenta Capital, Bain Capital Life Sciences, BlackRock, BVF Partners, Elikon Venture, Hillhouse Capital Group, Janus Henderson Investors, Legend Capital, Logos Capital, OrbiMed, RA Capital Management, TF Capital, Yonghua Capital |
| Jan 7, 2026 | Nocion Therapeutics | $23.0M Series B Extension | Pini Orbach, Monograph Capital | Canaan Partners, F-Prime Capital, Lumira Ventures, Mass General Brigham Ventures, Mission BioCapital, Osage University Partners |
| Oct 22, 2025 | Ampa | $8.5M Pre-Series A | John Propst, PhD, MBA | Morningside Ventures, Satori Neuro, Zabara Foundation |
| Oct 16, 2025 | Brook.ai | $28.0M Series B | Stephen Bruso, Eric Dickson | — |
| Aug 20, 2025 | Mira | $1.0M Other Equity | Pillar VC | Soma Capital, Village Global |
| Aug 1, 2025 | Cyted | $44.0M Series B | Carmine Circelli, Bruno Holthof | Advent Life Sciences, EQT Life Sciences, General Catalyst, BGF, HCA |
| Feb 6, 2025 | SimpliFed | $4.0M Other Equity | Morningside | — |
| Feb 1, 2025 | SimpliFed | $4.0M Seed | Morningside | Blackhorn Ventures, The Artemis Fund, The Venture Collective (TVC), American Heart Association, Cultivation Capital, New York Ventures, The Venture Collective, Waterline Ventures |
| Aug 21, 2024 | CairnSurgical | $4.5M Series A | Morningside Ventures | — |
| Jan 1, 2024 | ENYO Pharma | $28.0M Series C | OrbiMed, Morningside Ventures | Andera Partners, Earlybird Venture Capital, Kurma Partners, Pfizer Venture Investments, Pureos Bioventures, SR One, Third Rock Ventures, Wellington Partners, Vincent Brichard, Bpifrance |
| Dec 12, 2023 | Jitjatjo | $30.0M Series B | Morningside | — |
| Nov 1, 2023 | AdaptX | $10.0M Other Equity | YB Choi | Fortson VC, Feby Abraham, Morningside Ventures, Star Equity, WRF Capital |
| Oct 25, 2023 | Angitia Biopharmaceuticals | $46.0M Series B Extension | Morningside Ventures | 3H Health Investment, Legend Capital, OrbiMed |
| Aug 1, 2023 | Epigenic Therapeutics | $32.0M Series A | OrbiMed, Chen Kan | — |
| May 19, 2023 | Cyted | $16.7M Grant / Other Equity | Lucy Edwardes Jones, Anthony Aiudi | NHS |
| Apr 1, 2023 | GaeaStar | $7.0M Seed | — | DART Labs, at.inc/, Climate Capital, DART Ventures, Sand Hill Angels, VSC Ventures |
| Feb 1, 2023 | evonetix | $24.0M Series B | Foresite Capital | Matt Ocko, Dimension Capital, First Round Capital, Krishna Yeshwant, IA Ventures, K9 Ventures, Lux Capital, Northpond Ventures, Recode Ventures, Uncork Capital, UpHonest Capital, Y Combinator, Nat Goldhaber, Cambridge Consultants, Civilization Ventures, Data Collective, Nelly Markova, Providence Health & Services |
| Oct 6, 2022 | Valitor | $28.0M Series B | Morningside | Berkeley Catalyst Fund, ExSight Ventures, First Spark Ventures, Pandect Bioventures |
| Oct 1, 2022 | Resilience Lab | $4.0M Series A | Justin Burns, Stephen Raggio, Morningside, Viewside Capital Partners | Endeavor Venture Funds, Figure Eight Investments |
| Sep 7, 2022 | Otolith Labs | $20.0M Series A | Anthony Aiudi | — |
| Sep 1, 2022 | PsycApps | $1.7M Seed | Stephen Bruso | — |
| Aug 24, 2022 | AdvanCell | $12.4M Series B | Morningside | — |
| Aug 8, 2022 | Epigenic Therapeutics | $20.0M Pre-Series A | — | FountainBridge Capital, Kingray Capital, Michael Xue, Trinity Innovation Fund |
| Jun 1, 2022 | Airspace Link | $23.0M Series B | Avanta Ventures, David Li | 01 Advisors, 2048 Ventures, Andreessen Horowitz, Bowery Capital, BoxGroup, Founder Collective, Greylock, Hannah Grey, Indicator Ventures, Next47, Trajectory Ventures, Y Combinator, Gokul Rajaram, Greg Brockman, Henry Kravis, Dillon Krasnigor, Altos Ventures, Caprock, Detroit Venture Partners, Thales |
